title: Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association.
abstract: More than 1.2 million percutaneous coronary interventions are performed annually in the United States, with only an estimated 33% performed in women, despite the established benefits of percutaneous coronary intervention and adjunctive pharmacotherapy in reducing fatal and nonfatal ischemic complications in acute myocardial infarction and high-risk acute coronary syndromes. This statement reviews sex-specific data on the safety and efficacy of contemporary interventional therapies in women.
authors.forename: Alexandra J
authors.initials: AJ
authors.lastname: Lansky
authors.forename: Judith S
authors.initials: JS
authors.lastname: Hochman
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Ward
authors.forename: Gary S
authors.initials: GS
authors.lastname: Mintz
authors.forename: Rosalind
authors.initials: R
authors.lastname: Fabunmi
authors.forename: Peter B
authors.initials: PB
authors.lastname: Berger
authors.forename: Gishel
authors.initials: G
authors.lastname: New
authors.forename: Cindy L
authors.initials: CL
authors.lastname: Grines
authors.forename: Cody G
authors.initials: CG
authors.lastname: Pietras
authors.forename: Morton J
authors.initials: MJ
authors.lastname: Kern
authors.forename: Margaret
authors.initials: M
authors.lastname: Ferrell
authors.forename: Martin B
authors.initials: MB
authors.lastname: Leon
authors.forename: Roxana
authors.initials: R
authors.lastname: Mehran
authors.forename: Christopher
authors.initials: C
authors.lastname: White
authors.forename: Jennifer H
authors.initials: JH
authors.lastname: Mieres
authors.forename: Jeffrey W
authors.initials: JW
authors.lastname: Moses
authors.forename: Gregg W
authors.initials: GW
authors.lastname: Stone
authors.forename: Alice K
authors.initials: AK
authors.lastname: Jacobs
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000379:methods* / Q000401:mortality / Q000706:statistics & numerical data; D003327:Coronary Disease / Q000401:mortality / Q000628:therapy*; D004358:Drug Therapy / Q000379:methods* / Q000706:statistics & numerical data; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D012737:Sex Factors; D015607:Stents / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors